View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
June 24, 1997updated 05 Sep 2016 1:09pm


By CBR Staff Writer

Clarify Inc, the San Jose, California help desk company, has implemented a poison pill in the form of a shareholder rights plan to help ward off an unwanted take-over. It says the rights are designed to guard against partial tender offers and other abusive tactics that might be used to gain control of the company without paying all stockholders a fair price. Under the plan, the board is distributing, as a dividend, one right for each share held. If there is a bid for the company, or an attempt is made to buy 15% of the shares, each right can then be used to buy one one-thousandths of a newly issued share of preferred stock of the company at an exercise price of $95. Then, if a bidder moves in, holders can buy shares, to twice the value of this exercise price – instantly diluting the predator’s holding. The help desk market has been so buoyant that there have been predictions that financial and manufacturing software companies would like to enter the sector and a bid for a company like Clarify would be an obvious way to become a major force. Last year the company made a profit of $8.1m on revenue of $56m.

Content from our partners
Scan and deliver
GenAI cybersecurity: "A super-human analyst, with a brain the size of a planet."
Cloud, AI, and cyber security – highlights from DTX Manchester

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.